NCT01892540View on ClinicalTrials.gov

PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Breast CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DIAGNOSTIC_TEST

positron emission tomography/computed tomography

Undergo PET/CT

DIAGNOSTIC_TEST

PET/MRI

Undergo PET/MRI positron emission tomography/magnetic resonance imaging hybrid imaging

DEVICE

Position Device

Trial Locations (1)

44106-5065

Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT01892540 - PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer | Biotech Hunter | Biotech Hunter